Allergy/Imm

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Christiansen SC et al. – Potential options for the acute treatment of HAE will be discussed including purified C1INH, recombinant C1INH, an inhibitor of plasma kallikrein, and a B2–receptor antagonist. The arrival of these novel therapies promises to transform the future management of HAE.

Related Articles

Human C1-Esterase Inhibitor Concentrate (Berinert(R))
BioDrugs, 11/10/09    Relevance Score: 87%

Anaphylaxis and angioedema
Dermatology in Practice, 10/09/09    Relevance Score: 87%

Novel pathogenic mechanism and therapeutic approaches to angioedema associated with C1 inhibitor deficiency
Journal of Allergy and Clinical Immunology, 10/07/09    Relevance Score: 87%

Supraglottic swelling may not correlate with tongue swelling in angiotensin converting enzyme inhibitor-induced angioedema
The Laryngoscope, 11/06/09    Relevance Score: 84%

Pathogenesis and laboratory diagnosis of hereditary angioedema
Allergy and Asthma Proceedings, 10/09/09    Relevance Score: 84%

Today in Clinical Pharmacology...keeping you current

Hypersensitivity reactions to mAbs: 105 desensitizations in 23 patients, from evaluation to treatment
Journal of Allergy and Clinical Immunology, 11/25/09

Omalizumab for the treatment of exacerbations in children with inadequately controlled allergic (IgE-mediated) asthma
Journal of Allergy and Clinical Immunology, 11/25/09

High doses of inhaled corticosteroids during the first trimester of pregnancy and congenital malformations
Journal of Allergy and Clinical Immunology, 11/25/09

Today in Derm Allergy/Immunology...keeping you current

Granulomatous Dermatitis With Pseudoxanthoma Elasticum-Like Changes
Archives of Dermatology, 11/25/09

Familial atypical cold urticaria: Description of a new hereditary disease
Journal of Allergy and Clinical Immunology, 11/25/09

Failure of omalizumab in cholinergic urticaria
Clinical and Experimental Dermatology, 11/25/09


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Send this Summary to a Colleague

Enter email address